Journal article · 2015 · Open access
A plug-and-play approach to antibody-based therapeutics via a chemoselective dual click strategy
Nature Communications, 6(1), 6645 · Published 31 March 2015 · DOI 10.1038/ncomms7645
In brief
“A plug-and-play approach to antibody-based therapeutics via a chemoselective dual click strategy” is a 2015 journal article by Antoine Maruani and 5 co-authors, published in Nature Communications. OpenAlex counts 277 citations as of 21 November 2026, which puts it in the top 1% of works published in 2015 by citations. It is open access under a CC BY licence: the full text is free to read at Nature Communications.
- Citations
- 277
- Most cited in
- 2019 (36)
- Field-weighted impact
- 11.07
- References
- 41
- Authors
- 6
Abstract
Although recent methods for the engineering of antibody-drug conjugates (ADCs) have gone some way to addressing the challenging issues of ADC construction, significant hurdles still remain. There is clear demand for the construction of novel ADC platforms that offer greater stability, homogeneity and flexibility. Here we describe a significant step towards a platform for next-generation antibody-based therapeutics by providing constructs that combine site-specific modification, exceptional versatility and high stability, with retention of antibody binding and structure post-modification. The relevance of the work in a biological context is also demonstrated in a cytotoxicity assay and a cell internalization study with HER2-positive and -negative breast cancer cell lines.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Maruani, A., Smith, M. E. B., Miranda, E., Chester, K. A., Chudasama, V., & Caddick, S. (2015). A plug-and-play approach to antibody-based therapeutics via a chemoselective dual click strategy. Nature Communications, 6(1), 6645. https://doi.org/10.1038/ncomms7645
MLA 9
Maruani, Antoine, et al. “A plug-and-play approach to antibody-based therapeutics via a chemoselective dual click strategy.” Nature Communications, vol. 6, no. 1, 2015, p. 6645. https://doi.org/10.1038/ncomms7645.
Chicago
Maruani, Antoine, Mark E. B. Smith, Enrique Miranda, Kerry Ann Chester, Vijay Chudasama, and Stephen Caddick. 2015. “A plug-and-play approach to antibody-based therapeutics via a chemoselective dual click strategy.” Nature Communications 6 (1): 6645. https://doi.org/10.1038/ncomms7645.
Harvard
Maruani, A. et al. (2015) ‘A plug-and-play approach to antibody-based therapeutics via a chemoselective dual click strategy’, Nature Communications, 6(1), p. 6645. doi:10.1038/ncomms7645.
IEEE
A. Maruani, M. E. B. Smith, E. Miranda, K. A. Chester, V. Chudasama, and S. Caddick, “A plug-and-play approach to antibody-based therapeutics via a chemoselective dual click strategy,” Nature Communications, vol. 6, no. 1, p. 6645, 2015, doi: 10.1038/ncomms7645.
BibTeX
@article{maruani2015plug,
title = {{A plug-and-play approach to antibody-based therapeutics via a chemoselective dual click strategy}},
author = {Maruani, Antoine and Smith, Mark E. B. and Miranda, Enrique and Chester, Kerry Ann and Chudasama, Vijay and Caddick, Stephen},
journal = {Nature Communications},
year = {2015},
volume = {6},
number = {1},
pages = {6645},
doi = {10.1038/ncomms7645},
url = {https://doi.org/10.1038/ncomms7645}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2017 | 26 | |
| 2018 | 23 | |
| 2019 | 36 | |
| 2020 | 33 | |
| 2021 | 26 | |
| 2022 | 18 | |
| 2023 | 28 | |
| 2024 | 13 | |
| 2025 | 11 | |
| 2026 | 25 |
Its field-weighted citation impact is 11.07: it has been cited 11.07 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Physical Sciences › Chemistry › Organic Chemistry › Click Chemistry and Applications
- antibody-drug conjugates
- site-specific modification
- antibody engineering
- antibody stability
- cytotoxicity
- cellular internalization
- HER2-positive breast cancer
- HER2-negative breast cancer
Work with this paper
Most-cited papers in Chemistry
- CRC Handbook of Chemistry and PhysicsW.M. Haynes · CRC Press eBooks · 2014 · 58,210 citations
- Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.Harry Towbin, Th. Staehelin, J Gordon · Proceedings of the National Academy of Sciences · 1979 · 53,242 citations
- Crystal structure refinement with SHELXLGeorge M. Sheldrick · Acta Crystallographica Section C Structural Chemistry · 2014 · 45,305 citations
- Comparison of simple potential functions for simulating liquid waterWilliam L. Jorgensen, Jayaraman Chandrasekhar, Jeffry D. Madura and 2 more · The Journal of Chemical Physics · 1983 · 41,735 citations
- Equation of State Calculations by Fast Computing MachinesN. Metropolis, Arianna W. Rosenbluth, M. N. Rosenbluth and 2 more · The Journal of Chemical Physics · 1953 · 38,111 citations
Questions about this paper
How do I cite this paper in APA style?
Maruani, A., Smith, M. E. B., Miranda, E., Chester, K. A., Chudasama, V., & Caddick, S. (2015). A plug-and-play approach to antibody-based therapeutics via a chemoselective dual click strategy. Nature Communications, 6(1), 6645. https://doi.org/10.1038/ncomms7645
How many times has this paper been cited?
277 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Nature Communications: sign in and open the PDF from this page.
Who wrote this paper?
Antoine Maruani, Mark E. B. Smith, Enrique Miranda, Kerry Ann Chester, Vijay Chudasama, Stephen Caddick.
What is the DOI of this paper?
10.1038/ncomms7645, permanently at https://doi.org/10.1038/ncomms7645. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.